|
|
Volumn 43, Issue 6, 1979, Pages 2202-2206
|
|
Factors that affect response to chemotherapy and survival of patients with advanced head and neck cancer
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BLEOMYCIN;
DOXORUBICIN;
FLUOROURACIL;
METHOTREXATE;
MITOMYCIN C;
PORFIROMYCIN;
VINCRISTINE;
VINCRISTINE SULFATE;
ADVERSE DRUG REACTION;
CANCER CHEMOTHERAPY;
CANCER COMBINATION CHEMOTHERAPY;
CANCER MORTALITY;
DRUG ADMINISTRATION;
DRUG MIXTURE;
DRUG SCREENING;
DRUG THERAPY;
HEAD AND NECK CANCER;
HEAD CANCER;
HUMAN CELL;
LARYNX;
MAJOR CLINICAL STUDY;
MOUTH;
NECK CANCER;
PHARYNX;
THERAPY;
ADOLESCENT;
ADULT;
AGED;
ANTINEOPLASTIC AGENTS;
COMPARATIVE STUDY;
DISABILITY EVALUATION;
DRUG THERAPY, COMBINATION;
FEMALE;
HEAD AND NECK NEOPLASMS;
HUMAN;
MALE;
MIDDLE AGE;
PROGNOSIS;
REMISSION, SPONTANEOUS;
RETROSPECTIVE STUDIES;
SUPPORT, U.S. GOV'T, P.H.S.;
TIME FACTORS;
|
|
EID: 0018648121
PISSN: 0008543X
EISSN: 10970142
Source Type: Journal
DOI: 10.1002/1097-0142(197906)43:6<2202::AID-CNCR2820430607>3.0.CO;2-J Document Type: Article |
|
Times cited : (90)
|
|
References (15)
|
